There are 2934 resources available
Proffered Paper 1 – Genitourinary tumours, non-prostate - Invited Discussant LBA54 and LBA55
Presenter: Ignacio Duran Martinez
Session: Proffered Paper 1 – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
The famous ones: Circulating tumour cells (CTCs) and circulating free DNA (cfDNA)
Presenter: Michail Ignatiadis
Session: Meeting the liquid biopsy family
Resources:
Slides
Webcast
The truly Pandora’s box: Exosomes
Presenter: Christian Rolfo
Session: Meeting the liquid biopsy family
Resources:
Slides
Webcast
New frontiers: Spliced variants
Presenter: Martijn Lolkema
Session: Meeting the liquid biopsy family
Resources:
Slides
Webcast
Introduction
Presenter: Aurélien Marabelle
Session: Next challenges for cancer immunotherapy
Resources:
Slides
Webcast
Immunotherapy for locally advanced cancer
Presenter: Benjamin Besse
Session: Next challenges for cancer immunotherapy
Resources:
Slides
Webcast
Turning cold into hot tumours
Presenter: Aurélien Marabelle
Session: Next challenges for cancer immunotherapy
Resources:
Slides
Webcast
1056 - Primary 2-year (yr) results of a phase 2, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma
Presenter: Reinhard Dummer
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
2898 - Adjuvant immunotherapy with nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma patients with no evidence of disease (NED): A randomized, double-blind phase 2 trial (IMMUNED)
Presenter: Dirk Schadendorf
Session: Proffered Paper – Melanoma and other skin tumours
Resources:
Abstract
Proffered Paper 1 – Genitourinary tumours, non-prostate - Invited Discussant 901O and 902O
Presenter: Yohann Loriot
Session: Proffered Paper 1 – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast